Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
$86.28
Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
31 Oct 2025, 11:49
Chart & Data from iG
As Nike (NYSE: NKE) prepares to release its earnings report tomorrow, investors are closely watching the stock’s performance. Nike shares are currently trading around $73.07, with Wall Street analysts expecting an earnings per share (EPS) of $0.29—a 70% decline compared to last year.
Despite the anticipated drop in EPS, many analysts believe Nike is in a transition phase under its new CEO, aiming to restore the brand's dominance in the sportswear industry. While earnings estimates have been revised lower, this could increase Nike’s chances of beating expectations. In fact, last year, Nike outperformed Wall Street’s EPS estimates for all four quarters, suggesting that the current downturn might be the earnings trough before a growth rebound starting in May.
From a technical perspective, Nike’s stock is holding strong at long-term support dating back to 2015. However, a break below $67 could trigger additional selling pressure, requiring further evaluation.
On the upside, key resistance levels to watch include:
Additionally, the MACD indicator has turned bullish, signaling increased buying interest in recent weeks, which could support Nike’s stock price heading into the earnings report.
Much of the anticipated disappointment in earnings might already be priced into the stock, which could limit downside risk. Investors will be watching for Nike’s revenue growth outlook and future guidance to determine if this is the start of a broader recovery for the sports apparel giant.